Next-chemx Corporation 10-Q quarterly reports

NEXT-ChemX Corporation filed an amended quarterly report, restating financials due to auditor issues and reclassifying its core technology, while grappling with significant legal challenges and a substantial accumulated deficit.

NEXT-ChemX Corporation filed a restated quarterly report for Q2 2024, revealing significant financial adjustments, ongoing losses, and a legal dispute over 15.8 million shares.

NEXT-ChemX Corporation's latest 10-Q filing reveals significant financial deficiencies, auditor issues, and legal challenges, raising substantial doubt about its ability to continue as a going concern.

NEXT-ChemX Corporation's latest 10-Q/A filing reveals a significant accumulated deficit, ongoing losses, and substantial doubt about its ability to continue as a going concern, compounded by a legal battle over a large block of its common shares.

NEXT-ChemX Corporation files its Q1 2025 report, noting it is unaudited due to auditor transition, while continuing to advance its iTDE technology and facing ongoing legal proceedings.

NEXT-ChemX Corporation's Q3 2024 report is deemed deficient due to the inability of their new auditor to complete a review, while the company also faces legal challenges and going concern doubts.

NEXT-ChemX Corporation's Q2 2024 report reveals ongoing financial losses and operational challenges, including a change of auditors and a legal dispute over share ownership.

NEXT-ChemX Corporation's Q1 2024 report is deemed deficient due to the dismissal of their previous auditor and the inability of the new auditor to complete a review, raising concerns about the company's financial position and future viability.